Palantir Faces UK Privacy Backlash What It Means For NHS Contract Risk

Source Domain: finance.yahoo.com

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide.

A Labour led UK parliamentary committee has urged the government to remove Palantir Technologies from the £330m NHS Federated Data Platform contract.
The committee cites privacy, national data security, and a perceived mismatch with British values, and recommends using a 2027 break clause to seek alternative providers.
This move raises questions around Palantir’s position in sensitive government data projects, particularly in healthcare.

Palantir Technologies (NasdaqGS:PLTR) is in focus after the committee’s recommendation put its high profile NHS contract under pressure. The stock most recently closed at $152.17, with returns of 11.4% over the past week and 14.3% over the past year. Over a three year period, returns are described as very large, alongside a five year gain of 524.2%. This provides context for how the market has treated the company through earlier contract wins and controversies.

For investors, the committee’s stance raises questions about how much value the market assigns to long term, international public sector work, especially when there is renewed debate on privacy and national data control. The UK discussion may also influence how other governments and regulators think about awarding or renewing contracts with Palantir, which is worth watching if you are focused on the company’s exposure to sensitive public sector data platforms.

Wall Street’s queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab’s valuation page.

NasdaqGS:PLTR 1-Year Stock Price Chart

Is Palantir Technologies’s balance sheet strong enough for future acquisitions? Dive into our detailed financial…

Source